This review focuses on the use of “new” generation of non-adhesive liquid embolic agents
(NALEA). In literature, non-adhesive liquid embolic agents have mainly been used in the …

In this second of 3 review articles on the endovascular management of intracranial dural
AVFs, we discuss transarterial treatment approaches. The treatment goal is to occlude the …

Background and Objectives: Transcatheter arterial embolization (TAE) is part of the daily
practice of most interventional radiologists worldwide. The ideal liquid embolic agent is far …

Abstract Background Squid, as Onyx, is an ethylene-vinyl alcohol copolymer (EVOH)-based
liquid embolic agent developed for neuroradiologic interventions with poor application in …

Most intracranial dural arteriovenous fistulae (DAVFs) involve the transverse-sigmoid sinus
(TSS), and various types of endovascular treatment (EVT) have been involved in managing …

Dural arteriovenous fistulas (DAVFs) are complex vascular abnormalities that account for 10-
15% of intracranial vascular malformations. DAVFs are typically encountered in middle-aged …

Objectives: The use of non-adhesive gel-like embolic materials (NAGLEMs) in the
endovascular treatment of hypervascularized formations in the head and neck is gaining in …

Petroclival region dural arteriovenous fistulas (DAVFs) are rare and difficult lesions to
manage. They often have very complex anatomical structures and can be further divided into …

Objective Transarterial embolizatioin with transvenous balloon protection has been
described as a promising technique for intracranial dural arteriovenous fistula. The aim of …

Background During endovascular treatment of complex intracranial dural arteriovenous
fistulas (DAVFs) of the transverse sigmoid sinus, it can be difficult to preserve the patency of …